InMode Ltd. (INMD)

Market Cap	871.18M -32.6%
Revenue (ttm)	370.50M -6.2%
Net Income	93.83M -48.2%
EPS	1.43 -36.4%
Shares Out	63.36M
PE Ratio	9.62
Forward PE	9.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	815,865
Open	13.96
Previous Close	14.05
Day's Range	13.71 - 13.98
52-Week Range	13.14 - 19.78
Beta	2.17
Analysts	Hold
Price Target	16.75 (+21.82%)
Earnings Date	Feb 10, 2026

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. The ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2019
• Employees: 660
• Stock Exchange: NASDAQ
• Ticker Symbol: INMD
• Website: https://www.inmodemd.com

Financial Performance

In 2025, InMode's revenue was $370.50 million, a decrease of -6.16% compared to the previous year's $394.82 million. Earnings were $93.83 million, a decrease of -48.24%.

Analyst Summary

According to 6 analysts, the average rating for INMD stock is "Hold." The 12-month stock price target is $16.75, which is an increase of 21.82% from the latest price.

Price Target

$16.75

(21.82% upside)

Analyst Consensus: Hold